Product: CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP,  0.5 mg, 60 tablets (10 blister cards of 6 tablets each),  TEVA PHARMACEUTICALS USA, Sellersville PA 18960,  NDC #0555-0096-96
Reason for recall: Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Recall initiated: 20130207
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated